Company Filing History:
Years Active: 2005-2014
Title: Chris Allen Buhr: Innovator in Kinase Modulation
Introduction
Chris Allen Buhr is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that modulate protein kinase activity. With a total of 11 patents to his name, Buhr's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, Buhr has developed "Pyrazole kinase modulators and methods of use." This invention provides compounds that modulate protein kinase enzymatic activity, influencing cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. The compounds are designed to inhibit, regulate, and/or modulate kinases, offering methods for treating kinase-dependent diseases and conditions. Another notable patent is for "Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture." This invention focuses on compounds of Formula I and their pharmaceutically acceptable salts or solvates, along with methods for making and using these compounds.
Career Highlights
Throughout his career, Chris Allen Buhr has worked with notable companies such as Exelixis, Inc. and Signal Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and biochemistry.
Collaborations
Buhr has collaborated with talented individuals in his field, including Sunghoon Ma and Tae-Gon Baik. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Chris Allen Buhr is a distinguished inventor whose work in kinase modulation holds promise for future medical advancements. His contributions to the field are marked by a series of innovative patents that address critical health challenges.